| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Tnni3 ELISA Kit; Troponin I ELISA Kit; cardiac muscle ELISA Kit; Cardiac troponin I ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
cardiac troponin Ⅰ(cTn-Ⅰ) (TNNI3) is a biological molecule commonly studied in others research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P48787
Biological context
Researchers often monitor cardiac troponin Ⅰ(cTn-Ⅰ) in serum and plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in cardiac troponin Ⅰ(cTn-Ⅰ) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, cardiac troponin Ⅰ(cTn-Ⅰ) may also appear under names such as Tnni3 and Troponin I. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that cardiac troponin Ⅰ(cTn-Ⅰ) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Lipid Nanoparticle Delivery of Mesenchymal Stromal Cell-Derived microRNA 187-3p as a First-in-Class Therapy for Myocardial Dysfunction in Sepsis
AM Ektesabi, MC Barbosa-Silva, J Tsoporis,bioRxiv,2025
Validation Study of Animal Models for Gene Therapy-Induced Toxicity
한강민,Thesis & Dissertation,2025
Trim65 mitigates doxorubicin-induced myocardial injury by reducing ferroptosis
X Ma, Z Hu, L Xie, Z Li, H Liu, Z Li, Z Jiang,Experimental Cell Research,2025
Silica Nanoparticles Loaded With Selenium Quantum Dots Reduce Myocardial Ischemia-Reperfusion Injury by Alleviating Ferroptosis and Mitochondrial Dysfunction
T Li, B Yang, X Liu, D Shi, Z Wang,International Journal of Nanomedicine,2025
Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model
JH Ahn, J Lee, G Roh, NY Lee, HJ Bae, E Kwon,Archives of Toxicology,2024
METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes
C Huang, X Zhang, SX Wu, Q Chang,Cell Biology and Toxicology,2024
Cecal necroptosis triggers lethal cardiac dysfunction in TNF-induced severe SIRS
J Wu, T Ai, P He, Q Shi, Y Li, Z Zhang, M Chen,Cell Reports,2024
Involvement of neutrophils and macrophages in exhaustive exercise-induced liver, kidney, heart, and lung injuries
T Mizokami, K Suzuki,Exerc. Immunol. Rev,2024
PPARA ameliorates sepsis-induced myocardial injury via promoting macrophage M2 polarization by interacting with DUSP1
L Cheng,Regenerative therapy,2024
Apolipoprotein CIII in the pathophysiology of diabetes mellitus
IH Hasan,/,2024
Network Pharmacology and Experimental Validation to Explore Mechanism of Tetrahydropalmatine on Acute Myocardial Ischemia
P Lin,Chinese journal of integrative medicine,2023
Controlled Release of Hydrogen‐Carrying Perfluorocarbons for Ischemia Myocardium‐Targeting 19F MRI‐Guided Reperfusion Injury Therapy
C Nie,Advanced Science,2023
Endothelial ILK induces cardioprotection by preventing coronary microvascular dysfunction and endothelial-to-mesenchymal transition
P Reventun,Basic research in cardiology,2023
Inhibition of miR-143-3p alleviates myocardial ischemia reperfusion injury via limiting mitochondria-mediated apoptosis
CH Lu,Biological chemistry,2023
Binimetinib ameliorates the severity of septic cardiomyopathy by downregulating inflammatory factors
X Zheng,International immunopharmacology,2022
Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia
M Zhang,Pharmacological Research,2022
Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII
P Recio‐López,BioFactors,2022
Dihydrotanshinone I preconditions myocardium against ischemic injury via PKM2 glutathionylation sensitive to ROS
X Wu,Acta Pharmaceutica Sinica B,2022
Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41
Fan Deng,International journal of biological sciences,2022
Propionate alleviates myocardial ischemia-reperfusion injury aggravated by Angiotensin II dependent on caveolin-1/ACE2 axis through GPR41
F Deng,International Journal of Biological Sciences,2021
Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway
Y Liu,Oxidative Medicine and Cellular Longevity,2021
Inhibition of miR-128-3p Attenuated Doxorubicin-Triggered Acute Cardiac Injury in Mice by the Regulation of PPAR-γ
WB Zhang,PPAR Research,2021
Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia
D Yan,Journal of Controlled Release,2020
Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice
Y Hu,Scientific Reports,2020
Early label-free analysis of mitochondrial redox states by Raman spectroscopy predicts septic outcomes
M Wu,Journal of Advanced Research,2020
Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2
Y Zhao,Oxidative Medicine and Cellular Longevity ,2020
Evaluation of the cardioprotective effect of Casuarina suberosa extract in rats
Abd Al Haleem E N, et al,Drug and Chemical Toxicology,2019
Faculty of Biology and Medicine Publication
Schloss M J, et al,Cardiovascular Research,2019
Hyaluronic Acid Oligosaccharides Improve Myocardial Function Reconstruction and Angiogenesis against Myocardial Infarction by Regulation of Macrophages
Wang N,Theranostics,2019
Fine particulate matter-induced cardiovascular injury is associated with NLRP3 inflammasome activation in Apo E-/- mice
Du X, et al,Ecotoxicology and environmental safety,2019
2-arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction
Maximilian J Schloss.et al,Cardiovascular Research,2018
Synergistic effect of cranberry extract and losartan against aluminium chloride-induced hepatorenal damage associated cardiomyopathy in rats
Shereen Mohamed.et al,ARCH PHYSIOL BIOCHEM,2018
Cardioprotective effect of Shenxiong glucose injection on acute myocardial infarction in rats via reduction in myocardial intracellular calcium ion overload
Zhi-Hua Wang.et al,Tropical Journal of Pharmaceutical Research ,2017
Ultrafine carbon black disturbs heart rate variability in mice
Xiaofeng Jia et al,Toxicology Letters,2012